Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-15 18:30 |
Sanofi: Disclosure of trading in own shares
|
English | 12.0 MB | ||
| 2025-12-15 16:17 |
6-K
|
English | 34.8 KB | ||
| 2025-12-15 07:05 |
Press Release: Sanofi provides update on tolebrutinib in primary progressive mu…
|
English | 229.1 KB | ||
| 2025-12-15 07:05 |
Communiqué de presse : Sanofi fait le point sur le tolébrutinib dans la scléros…
|
French | 238.8 KB | ||
| 2025-12-15 07:00 |
Press Release : Sanofi provides update on tolebrutinib regulatory submission in…
|
English | 192.3 KB | ||
| 2025-12-15 07:00 |
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du …
|
French | 191.8 KB | ||
| 2025-12-12 18:26 |
6-K
|
English | 41.3 KB | ||
| 2025-12-11 07:00 |
Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care f…
|
English | 251.0 KB | ||
| 2025-12-11 07:00 |
Communiqué de presse : Qfitlia et Cablivi de Sanofi approuvés en Chine, élargis…
|
French | 252.7 KB | ||
| 2025-12-08 18:30 |
Sanofi : Déclaration des transactions sur actions propres
|
French | 10.5 MB | ||
| 2025-12-08 18:30 |
Sanofi: Disclosure of trading in own shares
|
English | 10.5 MB | ||
| 2025-12-04 11:00 |
Press Release: Sanofi completes acquisition of Vicebio
|
English | 136.5 KB | ||
| 2025-12-04 11:00 |
Communiqué de presse : Sanofi finalise l’acquisition de Vicebio
|
French | 142.1 KB | ||
| 2025-12-03 17:30 |
6-K
|
English | 32.2 KB | ||
| 2025-12-01 18:30 |
Sanofi: Disclosure of trading in own shares
|
English | 11.1 MB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
